TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
- A06 - Agentes contra el estreñimiento
- RESOLOR film-coated tablet 1 mg
- RESOLOR film-coated tablet 2 mg
- A16 - Otros productos para el tracto alimentario y metabolismo
- ELAPRASE concentrate for solution for infusion 6 mg/3 ml
- REPLAGAL concentrate for solution for infusion 1 mg/1 ml
- REVESTIVE powder and solvent for solution for injection 1.25 mg+0.5 ml
- REVESTIVE powder and solvent for solution for injection 5 mg+0.5 ml
- VPRIV powder for solution for infusion 200 IU
- VPRIV powder for solution for infusion 400 IU
- B06 - Otros agentes hematológicos
- FIRAZYR solution for injection 30 mg/10 ml
- TAKHZYRO SIRINGA PRERIEMPITA solution for injection 300 mg/2 ml
- TAKHZYRO solution for injection 300 mg/2 ml
- H02 - Corticosteroides para uso sistémico
- PLENADREN modified-release tablet 20 mg
- PLENADREN modified-release tablet 5 mg
- H05 - Homeostasis del calcio
- NATPAR powder and solvent for solution for injection 100 µg/dose
- NATPAR powder and solvent for solution for injection 25 µg/dose
- NATPAR powder and solvent for solution for injection 50 µg/dose
- NATPAR powder and solvent for solution for injection 75 µg/dose
- J05 - Antivirales de uso sistémico
- LIVTENCITY film-coated tablet 200 mg
- L01 - Antineoplásicos
- FRUZAQLA capsule, hard 1 mg
- FRUZAQLA capsule, hard 5 mg
- XAGRID capsule, hard 0.5 mg
- N06 - Psicoanalépticos
- EQUASYM modified-release capsule, hard 10 mg
- EQUASYM modified-release capsule, hard 20 mg
- EQUASYM modified-release capsule, hard 30 mg
- EQUASYM modified-release capsule, hard 40 mg
- EQUASYM modified-release capsule, hard 50 mg
- EQUASYM modified-release capsule, hard 60 mg
- V03 - Todos los demás preparados terapéuticos
- FOZNOL chewable tablet 1 000 mg
- FOZNOL chewable tablet 250 mg
- FOZNOL chewable tablet 500 mg
- FOZNOL chewable tablet 750 mg